IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces a Class Action Lawsuit Against Agile Therapeutics, Inc. & Advises Investo...
January 10 2017 - 2:10PM
Business Wire
Goldberg Law PC, a national shareholder rights litigation firm,
announces that it is investigating Agile Therapeutics, Inc.
(“Agile” or the “Company”) (Nasdaq: AGRX) concerning possible
violations of federal securities laws. Investors who purchased or
otherwise acquired Agile shares between March 9, 2016 and January
3, 2017 inclusive (the “Class Period”), are encouraged to contact
the firm in advance of the March 7, 2017 lead
plaintiff motion deadline.
If you purchased or otherwise acquired Agile shares and would
like more information regarding the investigation, we encourage you
to click here, or contact Michael Goldberg or Brian Schall, of
Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles,
CA 90067, at 800-977-7401, to discuss your rights without cost to
you. You can also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
Agile is a pharmaceutical company that develops and markets
prescription female contraceptive products.
On January 3, 2017, the Company revealed new data related to its
Phase 3 SECURE study measuring Agile’s combined hormonal
contraceptive patch product, Twirla. The FDA requested the study
after it rejected Agile's first marketing application in 2013.
The Company stated that nearly 2% of study participants suffered
"serious adverse events" including "deep vein thrombosis, pulmonary
embolism, gallbladder disease, ectopic pregnancy and depression."
Furthermore, 51.4% of subjects dropped out of the study.
When this information was released to the public, the value of
Agile stock fell almost 64%, causing investors severe harm.
If you have any questions concerning your legal rights, please
immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com, or email us at
info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170110006229/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2023 to Apr 2024